Cikkek nyilvánosan hozzáférhető megbízással - Miguel Angel Gómez BravoTovábbi információ
Sehol sem hozzáférhető: 6
Impact of early initiated everolimus on the recurrence of hepatocellular carcinoma after liver transplantation
M Rodriguez-Peralvarez, M Guerrero, L Barrera, G Ferrin, JM Alamo, ...
Transplantation 102 (12), 2056-2064, 2018
Megbízások: Government of Spain
Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients
MA Gómez‐Bravo, M Salcedo, C Fondevila, F Suarez, J Castellote, ...
The Journal of Clinical Pharmacology 53 (11), 1146-1154, 2013
Megbízások: Government of Spain
Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients
E Cordero, TA Aydillo, A Perez-Ordonez, J Torre-Cisneros, R Lara, ...
Transplantation 93 (8), 847-854, 2012
Megbízások: Government of Spain
Family caregivers of liver transplant recipients: Coping strategies associated with different levels of post-traumatic growth
MÁ Pérez-San-Gregorio, A Martín-Rodríguez, M Borda-Mas, ...
Transplantation Proceedings 50 (2), 646-649, 2018
Megbízások: Government of Spain
De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiency
I Aguilera, JM Sousa, MA Gómez-Bravo, A Núñez-Roldán
Digestive and Liver Disease 46 (7), 663-664, 2014
Megbízások: Government of Spain
How thinking about the donor influences post-traumatic growth in liver transplant recipients
A Martín-Rodríguez, MÁ Pérez-San-Gregorio, ML Avargues-Navarro, ...
Transplantation proceedings 50 (2), 610-612, 2018
Megbízások: Government of Spain
Valahol hozzáférhető: 28
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss
AJ Hessheimer, G de la Rosa, M Gastaca, P Ruíz, A Otero, M Gómez, ...
American Journal of Transplantation 22 (4), 1169-1181, 2022
Megbízások: Government of Spain
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
M Rodríguez‐Perálvarez, J Colmenero, A González, M Gastaca, A Curell, ...
American Journal of Transplantation 22 (6), 1671-1682, 2022
Megbízások: Government of Spain
Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
MA Rodríguez-Hernández, R Chapresto-Garzón, M Cadenas, ...
Cell Death & Disease 11 (5), 339, 2020
Megbízások: Government of Spain
Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor
HC Macher, G Suárez-Artacho, JM Guerrero, MA Gómez-Bravo, ...
PloS one 9 (12), e113987, 2014
Megbízások: Government of Spain
Post-traumatic growth and its relationship to quality of life up to 9 years after liver transplantation: a cross-sectional study in Spain
MÁ Pérez-San-Gregorio, A Martín-Rodríguez, M Borda-Mas, ...
BMJ open 7 (9), e017455, 2017
Megbízások: Government of Spain
Coping strategies in liver transplant recipients and caregivers according to patient posttraumatic growth
MÁ Pérez-San-Gregorio, A Martín-Rodríguez, M Borda-Mas, ...
Frontiers in Psychology 8, 18, 2017
Megbízások: Government of Spain
Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells
A Rodríguez-Hernández, E Navarro-Villarán, R González, S Pereira, ...
Redox biology 6, 174-182, 2015
Megbízások: Government of Spain
Circulating tumor cells enumeration from the portal vein for risk stratification in early pancreatic cancer patients
J Padillo-Ruiz, G Suarez, S Pereira, FJ Calero-Castro, J Tinoco, L Marin, ...
Cancers 13 (24), 6153, 2021
Megbízások: Government of Spain
Influence of donor liver CYP3A4* 20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients
MA Gómez-Bravo, M Apellaniz-Ruiz, M Salcedo, C Fondevila, F Suarez, ...
Pharmacogenetics and Genomics 28 (2), 41-48, 2018
Megbízások: Government of Spain
Differential antitumoral properties and renal-associated tissue damage induced by tacrolimus and mammalian target of rapamycin inhibitors in hepatocarcinoma: in vitro and in …
E Navarro-Villarán, J Tinoco, G Jiménez, S Pereira, J Wang, S Aliseda, ...
PLoS One 11 (8), e0160979, 2016
Megbízások: Government of Spain
Nanostructured fibrin agarose hydrogel as a novel haemostatic agent
R Campos‐Cuerva, B Fernández‐Muñoz, F Farfán López, ...
Journal of tissue engineering and regenerative medicine 13 (4), 664-673, 2019
Megbízások: Government of Spain
Prevalence and progression of chronic kidney disease after liver transplant: a prospective, real-life, observational, two-year multicenter study
JI Herrero, V Cuervas-Mons, MÁ Gómez-Bravo, J Fabregat, A Otero, ...
Revista Española de Enfermedades Digestivas 110 (9), 538-543, 2018
Megbízások: Government of Spain
miR-200c-3p, miR-222-5p, and miR-512-3p constitute a biomarker signature of sorafenib effectiveness in advanced hepatocellular carcinoma
P de la Cruz-Ojeda, T Schmid, L Boix, M Moreno, V Sapena, ...
Cells 11 (17), 2673, 2022
Megbízások: Government of Spain
Molecular pathways leading to induction of cell death and anti-proliferative properties by tacrolimus and mTOR inhibitors in liver cancer cells
E Navarro-Villarán, P Cruz, L Contreras, R González, M Negrete, ...
S. Karger AG, 2020
Megbízások: Government of Spain
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.